Researchers

еНаука >  Истраживачи >  Vučićević, Katarina

Vučićević, Katarina

IMG_6099.JPG picture


Rezultati 21-40 od 197
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2024The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease PatientsMagro, Fernando; ...; Vucicevic, Katarina M  ; (broj, koautora 24)Article
21aM21a
2024Integrating Clopidogrel’s First-Pass Effect in a Joint Semi-Physiological Population Pharmacokinetic Model of the Drug and Its Inactive Carboxylic Acid MetabolitePejčić, Zorica; Topić Vučenović, Valentina; Miljković, Branislava  ; Vučićević, Katarina  Article
21aM21a
2024Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical ApplicabilityJovanović, Marija  ; Homšek, Ana  ; Marković, Srđan; Kralj, Đorđe; Svorcan, Petar  ; Knežević Ivanovski, Tamara; Odanović, Olga; Vučićević, Katarina  Article
21M21
2024Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignanciesŠkorić, Biljana; Jovanović, Marija  ; Kuzmanović, Miloš  ; Miljković, Branislava  ; Vučićević, Katarina  Article
22M22
2024Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World PharmacokineticsMarković, Srđan  ; Kralj, Ðorđe; Svorcan, Petar  ; Knežević-Ivanovski, Tamara; Odanović, Olga; Obradović, Sanja; Homšek, Ana  ; Jovanović, Marija  ; Savić, Rada; Vučićević, Katarina  Article
21aM21a
2024Population Pharmacokinetic Model of Linezolid and Probability of Target Attainment in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation—A Step toward Correct DosingMilaković, Dragana; Kovačević, Tijana; Kovačević, Peđa; Barišić, Vedrana; Avram, Sanja; Dragić, Saša; Zlojutro, Biljana; Momčičević, Danica; Miljković, Branislava  ; Vučićević, Katarina  Article
21aM21a
2024Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational studyKovačević, Peđa; Milaković, Dragana; Kovačević, Tijana; Barišić, Vedrana; Dragić, Saša; Zlojutro, Biljana; Miljković, Branislava  ; Vučićević, Katarina  ; Rizwan, ZeeshanArticle
21M21
2024The influence of persistent organ damage on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patientsMagro, F; ...; Vucicevic, Katarina M  ; (broj, koautora 24)Conference Paper
Mp. category will be shown later
2023Farmakometrijski modeli – savremen alat za kvantifikaciju varijabilnosti i individualizaciju režima doziranja lekovaVučićević, Katarina  Conference Paper
Mp. category will be shown later
2023Lidocaine Clearance as Pharmacokinetic Parameter of Metabolic Hepatic Activity in Patients with Impaired LiverJovanović, Marija  ; Kovačević, Milena  ; Vezmar-Kovačević, Sandra  ; Palibrk, Ivan; Bjelanović, Jasna; Miljković, Branislava  ; Vučićević, Katarina  Article
23M23
2023Pharmacokinetic characterization, benefits and barriers of subcutaneous administration of monoclonal antibodies in oncologyHomšek, Ana  ; Spasić, Jelena  ; Nikolić, Neda  ; Stanojković, Tatjana  ; Jovanović, Marija  ; Miljković, Branislava  ; Vučićević, Katarina  Article
23M23
2023Methotrexate concentrations and associated variability factors in high dose therapy of children with acute lymphoblastic leukemia and non-Hodgkin lymphomaSkoric, Biljana; Kuzmanovic, Milos B; Jovanovic, Marija N  ; Miljkovic, Branislava R  ; Micic, Dragan D; Jovic, Milena; Jovanovic, Ankica; Vucicevic, Katarina M  Article
22M22
2023Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patientsMarković, Srđan  ; Kralj, Đorđe; Odanović, Olga; Homšek, Ana  ; Kalaba, Ana; Svorcan, Petar  ; Vučićević, Katarina  Conference Paper
Mp. category will be shown later
2023Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteriaJovanović, Marija  ; Kovačević, Milena  ; Catić-Đorđević, Aleksandra  ; Ćulafić, Milica  ; Stefanović, Nikola  ; Mitić, Branka  ; Vučićević, Katarina  ; Vezmar-Kovačević, Sandra  ; Veličković-Radovanović, Radmila  ; Miljković, Branislava  Article
23M23
2023Association of clozapine and norclozapine levels with patient and therapy characteristics—focus on interaction with valproic acidPanić, Bojana; Jovanović, Marija  ; Lukić, Vera  ; Vučićević, Katarina  ; Miljković, Branislava  ; Milovanović, Srđan  Article
22M22
2023Population pharmacokinetic model of infliximab in patients with fistulising Crohn’s diseaseHomšek, Ana  ; Marković, Srđan  ; Kralj, Đorđe; Odanović, Olga; Svorcan, Petar  ; Jovanović, Marija  ; Vučićević, Katarina  Conference Paper
Mp. category will be shown later
2023FarmakokinetikaPokrajac, Milena ; Miljković, Branislava  ; Vučićević, Katarina  Text book
Mp. category will be shown later
2023Modelling fatigue events in prostate cancer patients on radiotherapyRoganović, Maša  ; Stanojković, Tatjana  ; Nikitović, Marina  ; Petrović, Nina  ; Đurić, Ana  ; Matić, Ivana  ; Jovanović, Marija  ; Vučićević, Katarina  Conference Paper
Mp. category will be shown later
2023Review of the Clinical Pharmacokinetics, Efficacy and Safety of PembrolizumabHomšek Ana  ; Radosavljević Davorin  ; Miletić Nebojša  ; Spasić Jelena  ; Jovanović Marija  ; Miljković Branislava  ; Stanojković Tatjana  ; Vučićević Katarina  Article
22M22
2022Procena tehnike inhalacije farmaceuta u primarnoj zdravstvenoj zaštiti ‐ fokus na inhalatore za suvi prašakJovanović, Marija  ; Roganović, Maša  ; Kovačević, Milena  ; Ćulafić, Milica  ; Vučićević, Katarina  ; Vezmar-Kovačević, Sandra  ; Milenković, Branislava  ; Miljković, Branislava  Conference Paper
Mp. category will be shown later